Showing results (701-710 of 794) with videos related to

Sort By:
Pageof 80
Cell Cycle (Georgetown, Tex.)|May 12, 2015
Estrogen withdrawal, increased breast cancer risk and the KRAS-variantTerri P McVeigh, Song-Yi Jung, Michael J Kerin, et al.
European Urology Open Science|January 15, 2026
Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific OutcomesRyan M Putney, Purvish Trivedi, Shivanshu Awasthi, et al.
Biomedicines|February 25, 2022
Identification of Altered Evoked and Non-Evoked Responses in a Heterologous Mouse Model of Endometriosis-Associated PainMiguel A Tejada, Ana I Santos-Llamas, Lesley Escriva, et al.
Molecular Oncology|September 10, 2022
Increased MYBL2 expression in aggressive hormone-sensitive prostate cancerYuki Yoshikawa, Konrad H Stopsack, Xin Victoria Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2018
What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysisC L Vale, D J Fisher, I R White, et al.
The Journal of Urology|January 10, 2016
Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International CollaborationPatrizia Giannatempo, Gregory R Pond, Guru Sonpavde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2015
A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell CarcinomaSumanta Pal, Arun Azad, Shailender Bhatia, et al.
Urologic Oncology|May 22, 2014
Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2024
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized TrialsLucia Kwak, Praful Ravi, John G Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET TrialSebastian Medina, Naoto Tokuyama, Vaishnavi Putcha, et al.
Pageof 80